Haleon Spon Ads Each Rep 2 Ord Shs (HLN) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Haleon Spon Ads Each Rep 2 Ord Shs in September 2026.
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and others. The Company's segments include North America, Europe, Asia Pacific, and International. Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Haleon stock, with a target price indicating potential growth ahead.
Financial Health
Haleon is performing well with strong revenue and profits, indicating solid business operations.
Dividend
Haleon's projected dividend yield of 1.6% is modest and may appeal to some investors. If you invested $1000 you would be paid $16 a year in dividends (based on the last 12 months).
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
